Media coverage
7
Media coverage
Title GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer's Disease Media name/outlet Business Wire India Country/Territory India Date 02/24/22 Persons Pierre Magistretti Title GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer's Disease Media name/outlet TD Ameritrade Country/Territory United States Date 02/24/22 URL ct.moreover.com/?a=47110878099&p=1gw&v=1&x=5-PSXDDDuo-Kuhf7P6Fhfw Persons Pierre Magistretti Title GliaPharm SA and the Wyss Center Enter Collaboration to Develop.. Media name/outlet ADVFN UK Country/Territory United Kingdom Date 02/24/22 URL ct.moreover.com/?a=47110899321&p=1gw&v=1&x=zsyEzPDEfI1EqSDbP-2wyA Persons Pierre Magistretti Title GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer's ... Media name/outlet AETOS Wire Country/Territory United Arab Emirates Date 02/24/22 URL ct.moreover.com/?a=47113481836&p=1gw&v=1&x=jvQeyDtwfO41WTg_Q-83hA Persons Pierre Magistretti Title GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for... Media name/outlet AETOS Wire Country/Territory United Arab Emirates Date 02/24/22 URL ct.moreover.com/?a=47113251550&p=1gw&v=1&x=moKW4MO97YA3T_4OciEUVw Persons Pierre Magistretti Title GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer's Disease; The collaboration will accelerate the testing of GliaPharm's lead molecules in preclinical models of Alzheimer's disease and further the development of Media name/outlet Business Wire Country/Territory United States Date 02/24/22 Persons Pierre Magistretti Title GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer's Disease Media name/outlet FinanzNachrichten.de Country/Territory Germany Date 02/24/22 URL ct.moreover.com/?a=47110897721&p=1gw&v=1&x=XZpNqG-DKKw9LVPTmSezcA Persons Pierre Magistretti